Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568177 · ClinicalTrials.gov registry record · NA
Cardiac Autonomic Function in Women with Microvascular Coronary Dysfunction
A NA study of Microvascular Coronary Dysfunction, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 1
- Study location
NCT01568177 is a NA study of Microvascular Coronary Dysfunction that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 105 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01568177, a NA study of Microvascular Coronary Dysfunction, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
Microvascular coronary dysfunction (MCD) (abnormities in small blood vessels/arteries in heart) with symptoms of persistent chest pain impacts women. There are an estimated 2-3 million women in the US with MCD and about 100,000 new cases annually. Autonomic nervous system (ANS) is part of the central nervous system to help people adapt to changes in their environment. It controls what are normally involuntary activities, such as heart rate, respiration (breathing), body temperature, blood pressure, and urinary function. However, there is a limited understanding of the role of ANS in MCD. This research is proposed to investigate cardiovascular reactivity to mental stress and the cardiac (heart) nervous system in women with MCD using mental stress testing, peripheral vascular testing, advanced cardiac imaging and cardiac autonomic function testing. 100 participants will be recruited in the next five years.
Conditions Studied
Interventions
- BEHAVIORAL Mental Stress Testing
- OTHER Peripheral Arterial Tonometry (PAT) Testing
- OTHER Heart Rate Variability (HRV)
- OTHER RESPeRATE Breathing Trial
- PROCEDURE SPECT cardiac scan with 123I-mIBG and Myoview
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2011-02 |
| Est. Completion | 2024-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568177
The ClinicalTrials.gov registry entry for NCT01568177 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Microvascular Coronary Dysfunction appearing as the primary indexed condition, and to 5 interventions - of which Mental Stress Testing is the first listed.
NCT01568177 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01568177 about?
NCT01568177 is a clinical study titled "Cardiac Autonomic Function in Women with Microvascular Coronary Dysfunction". Microvascular coronary dysfunction (MCD) (abnormities in small blood vessels/arteries in heart) with symptoms of persistent chest pain impacts women. There are an estimated 2-3 million women in the US with MCD and about 100,000 new cases annually. Autonomic nervous system (ANS) is part of the centra...
What is the current status of trial NCT01568177?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2011-02. Estimated completion is 2024-02.
What conditions does trial NCT01568177 study?
This clinical trial studies the following conditions: Microvascular Coronary Dysfunction.
What interventions are being tested in trial NCT01568177?
The interventions under investigation include: Mental Stress Testing (BEHAVIORAL), Peripheral Arterial Tonometry (PAT) Testing (OTHER), Heart Rate Variability (HRV) (OTHER), RESPeRATE Breathing Trial (OTHER), SPECT cardiac scan with 123I-mIBG and Myoview (PROCEDURE).
Who is sponsoring clinical trial NCT01568177?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01568177 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microvascular Coronary Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.